HomeInsightsPE

Biofil Chemicals & Pharmaceuticals Ltd PE Ratio

Biofil Chemicals & Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

4.2 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 13, 2024

Image

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM

PE

191.9

Last updated on: Dec 13, 2024

Key Highlights

  • The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 191.9 as of 13 Dec 9.00 AM .
  • The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 22 on March 2019 to 137.2 on March 2024 . This represents a CAGR of 35.67% over 6 years.
  • The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 63.31 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd

No data available

Company Fundamentals for Biofil Chemicals & Pharmaceuticals Ltd

No data available

Image

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM

Share Price

₹ 63.31

-1.38 (-2.13%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Biofil Chemicals & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Biofil Chemicals & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 202463.31
11 Dec 202464.69
10 Dec 202464.93
09 Dec 202464.9
06 Dec 202465.61
05 Dec 202466.24
04 Dec 202465.23
03 Dec 202466.22
02 Dec 202466.47
29 Nov 202462.75

SWOT Analysis Of Biofil Chemicals & Pharmaceuticals Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Biofil Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Biofil Chemicals & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Biofil Chemicals & Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in %

About Biofil Chemicals & Pharmaceuticals Ltd

  • Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
  • Later on, the Company was converted into a Public Limited Company on 7 May '92.
  • The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
  • It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
  • The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

Biofil Chemicals & Pharmaceuticals Ltd News Hub

News

Biofil Chemicals & Pharmaceuticals standalone net profit declines 29.17% in the June 2024 quarter

Net profit of Biofil Chemicals & Pharmaceuticals declined 29.17% to Rs 0.17 crore in the q...

Read more

2024-08-14 00:00:00

News

Biofil Chemicals & Pharmaceuticals to table results

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

2024-08-12 00:00:00

News

Biofil Chemicals & Pharmaceuticals AGM scheduled

Biofil Chemicals & Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of...

Read more

2024-09-10 00:00:00

News

Biofil Chemicals & Pharmaceuticals to conduct board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Co...

Read more

2024-11-08 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Biofil Chemicals & Pharmaceuticals Ltd

What is the current PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd?

The Current PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 191.85 as on 13 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Dec 2024.

What was the PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd last year?

The PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd was 121.88 last year, now the PE ratio is 191.85, showing a year-on-year growth of 57.4%.

What does the PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 191.85. This ratio indicates that investors are willing to pay 191.85 times the earnings per share for each share of Biofil Chemicals & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Biofil Chemicals & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd grew by 57.4% whereas, the EPS ratio grew by -90.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions